Shinewell Pharmaceuticals Private Limited
About Shinewell Pharmaceuticals Private Limited
Data last updated:
Shinewell Pharmaceuticals Private Limited is a private limited company based in Nalasopara West, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 01 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2016PTC280513. Its GSTIN is 27AAXCS0589C1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Prabhakar Upadhyay and Abhishek Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B/106 Deep Apartment Nilegaon Nilemore, Nalasopara West, Maharashtra, India – 401203.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.69 Lakh, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹2.64 Lakh (net margin -24.7%) and EBITDA of -₹2.63 Lakh (EBITDA margin -24.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shinewell Pharmaceuticals Private Limited's registered office is in Nalasopara West, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB/106 Deep Apartment Nilegaon Nilemore, Nalasopara West, Maharashtra, India – 401203
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Shinewell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shinewell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shinewell Pharmaceuticals Private Limited, buy the company report.
Financials of Shinewell Pharmaceuticals Private Limited
FY 2025 filings availableShinewell Pharmaceuticals Private Limited reported revenue of ₹10.69 Lakh (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 2% growth in the latest year. EBITDA fell 176% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24.6% | ||||
| Net Profit Margin | -24.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shinewell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shinewell Pharmaceuticals Private Limited
Shinewell Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Prabhakar Upadhyay | Director | 01 May 2016 | 10 Years 6 Months | Current |
| Abhishek Kumar Singh | Director | 01 May 2016 | 10 Years 6 Months | Current |
| Saurabh Kumar Upadhyay | Director | 01 May 2016 | 10 Years 6 Months | Current |
Peer comparison
Shinewell Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ak Pharmaceuticals Private Limited | ₹10.76 Lakh (FY 2025) | 22.0% | New Delhi, Delhi, India | |||
| Gabreal Pharmaceuticals Pvt Ltd | ₹10.73 Lakh (FY 2023) | -8.0% | Dombivli, Maharashtra, India | |||
| Lukem Pharmaceuticals Private Limited | ₹10.73 Lakh (FY 2025) | -30.0% | Patna, Bihar, India | |||
| Shinewell Pharmaceuticals Private Limitedthis company | ₹10.69 Lakh (FY 2024) | -₹2.64 Lakh | -24.7% | 2.0% | Nalasopara West, Maharashtra, India | |
| Willcare Pharmaceuticals Private Limited | ₹10.65 Lakh (FY 2025) | 60.0% | Umaria, Madhya Pradesh, India |
To see the full peer comparison of Shinewell Pharmaceuticals Private Limited, buy the company report.
Auditor
Shinewell Pharmaceuticals Private Limited is audited by AVESHAMRUTLALPATEL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AVESHAMRUTLALPATEL | FY 2017 | 125396 |
Shareholding
The shareholding of Shinewell Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Shinewell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shinewell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shinewell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shinewell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS0589C1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shinewell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shinewell Pharmaceuticals Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Abhishek Kumar Singh was appointed as Director on 01 May 2016.
Frequently asked questions
Shinewell Pharmaceuticals is an active private limited company based in Nalasopara West, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 01 May 2016 (10+ years old) and is registered under CIN U51397MH2016PTC280513.
Shinewell Pharmaceuticals has 3 current directors:
- Sandeep Prabhakar Upadhyay - Director
- Abhishek Kumar Singh - Director
- Saurabh Kumar Upadhyay - Director
The latest financial statements of Shinewell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Shinewell Pharmaceuticals is 27AAXCS0589C1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shinewell Pharmaceuticals is U51397MH2016PTC280513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shinewell Pharmaceuticals was incorporated on 01 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Shinewell Pharmaceuticals by revenue are Ak Pharmaceuticals Private Limited, Gabreal Pharmaceuticals Pvt Ltd, Lukem Pharmaceuticals Private Limited, Willcare Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Kumar Singh was appointed as Director on 01 May 2016. Sandeep Prabhakar Upadhyay was appointed as Director on 01 May 2016. Saurabh Kumar Upadhyay was appointed as Director on 01 May 2016.
The registered office of Shinewell Pharmaceuticals is at B106 Deep Apartment Nilegaon Nilemore, Nalasopara West, Maharashtra, India – 401203.
Shinewell Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Shinewell Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
